Immunic Therapeutics

Immunic is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Immunic Therapeutics Information

Geographic Data

Immunic Therapeutics headquarters map

Address:

City: New York

State: New York

Zip:

Country: United States

Financial Info

Stage:

post ipo equity

Raised Last:

$45M

Raised Total:

$224M

Metrics

2,831,244Website Global Rank

5,716Website Monthly Traffic

Twitter Followers

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products: its lead development program, IMU-838, a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH and exhibits a host-based antiviral effect, is currently being developed as a treatment option for multiple sclerosis, ulcerative colitis, Crohn&s;s disease, and primary sclerosing cholangitis. IMU-935, a selective inverse agonist of the transcription factor RORγt, is targeted for development in psoriasis, castration-resistant prostate cancer and Guillain-Barré syndrome. IMU-856, which targets the restoration of the intestinal barrier function, is targeted for development in diseases involving bowel barrier dysfunction.

Contact Phone:

Contact Email:

Immunic Therapeutics went public on 4/15/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/15/2019

Ticker Symbol:
IMUX

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2022 Post-IPO Equity 11 $60M Vivo Capital
Sphera Global Healthcare Fund
RTW Investments
Parkman Healthcare Partners
Logos Capital
Invus
Great Point Partners
Deep Track Capital
Commodore Capital
BVF Partners
Vivo Capital
Sphera Global Healthcare Fund
RTW Investments
Parkman Healthcare Partners
Logos Capital
Invus
Great Point Partners
Deep Track Capital
Commodore Capital
BVF Partners
4/2020 Post-IPO Equity $15M
8/2020 Post-IPO Equity $103.5M
6/2020 Post-IPO Equity $25M
7/2021 Post-IPO Equity $45M
9/2016 Series A 4 $19.6M Life Sciences Partners
LifeCare Partners
Bayern Kapital
High-Tech Grunderfonds
Life Sciences Partners
LifeCare Partners
8/2019 Grant 1 - German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
2/2017 Series A 3 $4.3M bmp Ventures
LifeCare Partners
LSP BioVentures
LSP BioVentures
bmp Ventures
LifeCare Partners
LSP BioVentures
LSP BioVentures
9/2017 Series A 6 $11.9M Life Sciences Partners
Omega Funds
IBG Risikokapitalfonds II GmbH &a; Co. KG
Fund+
Bayern Kapital
LifeCare Partners
Fund+
Omega Funds
Life Sciences Partners
Omega Funds
IBG Risikokapitalfonds II GmbH &a; Co. KG
Fund+
Bayern Kapital
LifeCare Partners
Fund+
Omega Funds
8/2019 Grant 1 - German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF)
Announced Date Name Price
4/2019 Vital Therapies

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research